BPA against VA schedule #V797P-7347A for reagents and consumables.
Ended Awarded Last action
- Contract number
- FA239625FB113
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Air Force
Department of Defense
- Obligated
- $288,642
Award facts
- Contract value 100% obligated
- $288,642.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- WPAFB, OH 45433, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $288,642 |
About this award
The Defense Health Agency has awarded a Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation, a global manufacturer of in vitro diagnostic products and laboratory equipment, for the provision of reagents and consumables. This contract is a child award under the VA Schedule V797P-7347A and carries a ceiling value of $288,642.16 under firm fixed-price terms. The award was made on April 30, 2025, with an ultimate completion date of May 2, 2025, and no set-aside designation was utilized in the competitive procurement.
The contract represents a continuation of Roche Diagnostics' substantial presence in the federal healthcare marketplace, where the company supplies critical diagnostic technologies to support military and veterans healthcare systems. As a foreign-owned, for-profit entity, Roche Diagnostics competes openly in federal procurement and holds multiple significant IDCs and BPAs across federal agencies under GSA Schedule vehicles, including the Critical Analyzers, Laboratory (FSS-66-III) schedule, under which this award is structured. The reagents and consumables procured under this BPA support the Defense Health Agency's laboratory diagnostic capabilities across its medical facilities, enabling advanced testing for infectious diseases, chronic conditions, and point-of-care applications essential to military healthcare delivery.
Quick answers
Who was awarded contract FA239625FB113?
FA239625FB113 was awarded to Roche Diagnostics Corporation by Air Force (Department of Defense) on April 30, 2025.
How much is contract FA239625FB113 worth?
The government has obligated $288,642 on FA239625FB113.
Which agency awarded contract FA239625FB113?
Air Force (Department of Defense) awarded FA239625FB113, with funding from Defense Health Agency (Department of Defense).
Is contract FA239625FB113 an order under another contract?
Yes. FA239625FB113 is a BPA call under V797P7347A-FA860120A0001, a blanket purchase agreement, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract FA239625FB113 competed?
The extent of competition for FA239625FB113 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award